WHERE THERAPIES GO VIRAL
Live / Applied — Non-final action mailed (as of 02 Feb 2026)
What this means for you
Not registered yet, but its 25 Sept 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99413260
- Mark type
- Stylized text
- Filed
- 25 Sept 2025
- Attorney of record
- Michelle L. Zimmermann
Goods and services
- Class 042 — Scientific and technological services: Medical and scientific research and development in the fields of cancer treatment and oncolytic virotherapy; Research and development of bio-pharmaceuticals for the treatment of cancer; Medical and scientific research in the fields of genetics and oncology; Research and development of technology in the fields of stem cells and stem cell therapy; Development of therapeutics and cell therapies; Scientific research and development of cell therapies, namely, chimeric antigen receptor T-cells (CAR-T) to cure solid tumor cancers and other cancers; Medical and scientific research services in the fields of genetics, cell therapy, oncology, immuno-oncology
Owner
- Vyriad, Inc., Rochester, MN, US
Prosecution history
- 02 Feb 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 02 Feb 2026 — NON-FINAL ACTION E-MAILED
- 02 Feb 2026 — NON-FINAL ACTION WRITTEN
- 02 Feb 2026 — ASSIGNED TO EXAMINER
- 25 Sept 2025 — APPLICATION FILING RECEIPT MAILED
- 25 Sept 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 25 Sept 2025 — NEW APPLICATION ENTERED